Druggability analysis and classification of protein tyrosine phosphatase active sites

被引:37
|
作者
Ghattas, Mohammad A. [1 ]
Raslan, Noor [1 ]
Sadeq, Asil [1 ]
Al Sorkhy, Mohammad [1 ]
Atatreh, Noor [1 ]
机构
[1] Al Ain Univ Sci & Technol, Coll Pharm, POB 64141, Al Ain, U Arab Emirates
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2016年 / 10卷
关键词
PTP1B; oral bioavailability; drug-like inhibitors; drug design; active site; allosteric site; MPtpB; CD45; SHP2; YopH; VIRTUAL SCREENING APPROACH; STRUCTURE-BASED DESIGN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SELECTIVE INHIBITORS; INSULIN SENSITIVITY; DRUG DISCOVERY; 1B; POTENT; PTP1B;
D O I
10.2147/DDDT.S111443
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein tyrosine phosphatases (PTP) play important roles in the pathogenesis of many diseases. The fact that no PTP inhibitors have reached the market so far has raised many questions about their druggability. In this study, the active sites of 17 PTPs were characterized and assessed for its ability to bind drug-like molecules. Consequently, PTPs were classified according to their druggability scores into four main categories. Only four members showed intermediate to very druggable pocket; interestingly, the rest of them exhibited poor druggability. Particularly focusing on PTP1B, we also demonstrated the influence of several factors on the druggability of PTP active site. For instance, the open conformation showed better druggability than the closed conformation, while the tight-bound water molecules appeared to have minimal effect on the PTP1B druggability. Finally, the allosteric site of PTP1B was found to exhibit superior druggability compared to the catalytic pocket. This analysis can prove useful in the discovery of new PTP inhibitors by assisting researchers in predicting hit rates from high throughput or virtual screening and saving unnecessary cost, time, and efforts via prioritizing PTP targets according to their predicted druggability.
引用
收藏
页码:3197 / 3209
页数:13
相关论文
共 50 条
  • [31] Molecular analysis of receptor protein tyrosine phosphatase μ-mediated cell adhesion
    Aricescu, AR
    Hon, WC
    Siebold, C
    Lu, WX
    van der Merwe, PA
    Jones, EY
    EMBO JOURNAL, 2006, 25 (04): : 701 - 712
  • [32] Catalytically active membrane-distal phosphatase domain of receptor protein-tyrosine phosphatase α is required for Src activation
    Vacaru, Andrei M.
    den Hertog, Jeroen
    FEBS JOURNAL, 2010, 277 (06) : 1562 - 1570
  • [33] Tyrosine inhibits the Mycobacterium tuberculosis protein tyrosine phosphatase MptpA
    Alessandra Stefan
    Chiara Palazzetti
    Alejandro Hochkoeppler
    Journal of Proteins and Proteomics, 2023, 14 (3) : 175 - 180
  • [34] INHIBITION OF TYROSINE DEPHOSPHORYLATION BY A CATALYTICALLY INACTIVE PROTEIN TYROSINE PHOSPHATASE
    MILARSKI, KL
    ZHANG, ZY
    DIXON, JE
    SALTIEL, AR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 312 - 312
  • [35] Regulation of ROMK channels by protein tyrosine kinase and tyrosine phosphatase
    Wang, WH
    Lin, DH
    Sterling, H
    TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (03) : 138 - 142
  • [36] Expression analysis and essential role of the putative tyrosine phosphatase His-domain-containing protein tyrosine phosphatase (HD-PTP)
    Gingras, Marie-Claude
    Kharitidi, Dmitri
    Chenard, Valerie
    Uetani, Noriko
    Bouchard, Maxime
    Tremblay, Michel L.
    Pause, Arnim
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2009, 53 (07): : 1069 - 1074
  • [37] Functions of the ectodomain and cytoplasmic tyrosine phosphatase domains of receptor protein tyrosine phosphatase Dlar in vivo
    Krueger, NX
    Reddy, RS
    Johnson, K
    Bateman, J
    Kaufmann, N
    Scalice, D
    Van Vactor, D
    Saito, H
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (19) : 6909 - 6921
  • [38] Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B
    van Montfort, RLM
    Congreve, M
    Tisi, D
    Carr, R
    Jhoti, H
    NATURE, 2003, 423 (6941) : 773 - 777
  • [39] Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22
    Blasioli, J
    Paust, S
    Thomas, ML
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 2303 - 2307
  • [40] The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes
    Zhang, Yanhui
    Du, Yongli
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (19) : 2345 - 2367